Akira Sawaki

Summary

Affiliation: Aichi Cancer Center
Country: Japan

Publications

  1. ncbi Clinical impact of radiotherapy for locally advanced pancreatic cancer
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
    J Gastroenterol 44:1209-14. 2009
  2. ncbi Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, 464 0021 Nagoya, Japan
    Cancer Chemother Pharmacol 54:S44-9. 2004
  3. ncbi Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
    J Gastroenterol Hepatol 23:1292-7. 2008
  4. ncbi Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Aichi 464 8681, Japan
    Cancer Chemother Pharmacol 65:961-7. 2010
  5. ncbi Improvement of oral intake following chemotherapy in gastric cancer patients with an inability to eat
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
    Oncology 79:211-8. 2010
  6. ncbi Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese
    Junya Kanda
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya, Japan
    Cancer Sci 100:296-302. 2009
  7. ncbi Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction
    Kazuo Hara
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Am J Gastroenterol 106:1239-45. 2011
  8. ncbi Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, and Department of Epidemiology, Nagoya University Graduate School of Medicine, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Aichi, Japan
    Cancer Epidemiol Biomarkers Prev 19:1311-9. 2010
  9. ncbi Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Japan
    Asian Pac J Cancer Prev 11:447-52. 2010
  10. ncbi Clinical efficacy and safety of sunitinib after imatinib failure in Japanese patients with gastrointestinal stromal tumor
    Kazuya Matsumoto
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    Jpn J Clin Oncol 41:57-62. 2011

Collaborators

Detail Information

Publications60

  1. ncbi Clinical impact of radiotherapy for locally advanced pancreatic cancer
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
    J Gastroenterol 44:1209-14. 2009
    ..The aim of this study was to compare the survival benefits associated with gemcitabine and concurrent chemoradiotherapy in locally advanced unresectable PC...
  2. ncbi Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, 464 0021 Nagoya, Japan
    Cancer Chemother Pharmacol 54:S44-9. 2004
    ..While several issues remain, they should be clarified by the current clinical trials and associated laboratory studies...
  3. ncbi Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
    J Gastroenterol Hepatol 23:1292-7. 2008
    ..The aim of this study was to identify factors that predict treatment outcome in patients with metastatic pancreatic cancer treated with gemcitabine, and then to use these factors to develop a practical prognostic index...
  4. ncbi Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Aichi 464 8681, Japan
    Cancer Chemother Pharmacol 65:961-7. 2010
    ..The aim of this single-arm phase II clinical study was to assess the efficacy and safety of single-agent motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate...
  5. ncbi Improvement of oral intake following chemotherapy in gastric cancer patients with an inability to eat
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
    Oncology 79:211-8. 2010
    ..However, these studies included patients able to maintain sufficient oral intake, and the effectiveness of chemotherapy for patients unable to eat remained unclear...
  6. ncbi Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese
    Junya Kanda
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya, Japan
    Cancer Sci 100:296-302. 2009
    ..09 (1.30–12.85)]. These results indicate that alcohol has an impact on PC risk when the effects of alcohol consumption and metabolism are combined. Acetaldehyde may be involved in the mechanisms underlying PC development...
  7. ncbi Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction
    Kazuo Hara
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Am J Gastroenterol 106:1239-45. 2011
    ..However, prospective studies of EUS-CDS have not yet been performed. We conducted a prospective study to evaluate the safety, feasibility, and efficacy of EUS-CDS in patients with malignant lower biliary tract obstruction...
  8. ncbi Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, and Department of Epidemiology, Nagoya University Graduate School of Medicine, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Aichi, Japan
    Cancer Epidemiol Biomarkers Prev 19:1311-9. 2010
    ..However, to our knowledge, there are no reports that evaluate simultaneously the effects of folate intake and genetic polymorphisms on clinical outcome of gastric cancer patients...
  9. ncbi Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Japan
    Asian Pac J Cancer Prev 11:447-52. 2010
    ..The purpose of this analysis was to evaluate the impact of genetic polymorphisms of the ABCB1 gene on clinical outcomes in patients with advanced gastric cancer (AGC) treated with second-line chemotherapy...
  10. ncbi Clinical efficacy and safety of sunitinib after imatinib failure in Japanese patients with gastrointestinal stromal tumor
    Kazuya Matsumoto
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    Jpn J Clin Oncol 41:57-62. 2011
    ..However, early clinical reports have shown that sunitinib has substantial anticancer activity in patients with advanced gastrointestinal stromal tumor after failure of imatinib...
  11. ncbi Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography
    Noriyuki Hoki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    J Gastroenterol 44:154-9. 2009
    ..These criteria require distinguishing AIP from neoplastic lesions. However, this can be difficult, and patients often undergo surgery on the basis of suspected pancreatic cancer (PC)...
  12. ncbi Interventional endoscopic ultrasonography
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    J Gastroenterol Hepatol 24:509-19. 2009
    ..In this review, we particularly focus on the present and future roles of interventional EUS, including EUS-FNA and therapeutic EUS...
  13. ncbi A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-0021, Japan
    J Gastroenterol 39:329-33. 2004
    ..Early clinical reports have shown that imatinib mesylate (STI571) produces substantial anticancer activity in patients with metastatic or unresectable GIST...
  14. ncbi Endoscopic ultrasound-guided ethanol injection in the pancreas in a porcine model: a preliminary study
    Kakuya Matsumoto
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    J Gastroenterol Hepatol 23:e1-6. 2008
    ..Local progression is problematic, and minimally invasive procedures allowing locoregional control are needed. In this study, we attempted endoscopic ultrasound (EUS)-guided injection of ethanol into the pancreas...
  15. ncbi Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report
    Kakuya Matsumoto
    Department of Gastroenterology, Aichi Cancer Center, Nagoya, Japan
    Gastrointest Endosc 57:269-71. 2003
  16. ncbi Pancreatic endocrine neoplasm can mimic serous cystadenoma
    Hiroshi Imaoka
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden Chikusa ku, Nagoya, Japan
    Int J Gastrointest Cancer 35:217-20. 2005
    ..This case suggests that it is very difficult to distinguish PENs from SCAs based solely on imaging methods. EUS-FNAB is essential for determining the appropriate therapeutic strategy, as it provides the histopathological diagnosis...
  17. ncbi Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis
    Hai xing Ju
    Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
    Am J Pathol 178:1835-46. 2011
    ..In addition, most methylation status in stage IV CRCs seems to be established before metastasis...
  18. ncbi Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Aichi 464 8681, Japan
    Gastric Cancer 14:155-60. 2011
    ....
  19. ncbi Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
    Daisuke Ennishi
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
    Cancer Sci 102:2231-5. 2011
    ..In conclusion, we observed a significant association between IGF1 polymorphisms and stomach cancer risk among a Japanese population. Examination of the biological significance of IGF1 is warranted...
  20. ncbi Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
    Minoru Shigekawa
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    J Hepatobiliary Pancreat Sci 17:269-74. 2010
    ..This study aimed to evaluate the pattern of FDG accumulation, and the change in FDG uptake after steroid treatment in AIP and PC...
  21. ncbi Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma
    Reiko Takayama
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Aichi 464 0021, Japan
    J Gastroenterol 45:52-9. 2010
    ..Serum biomarkers for the early detection of pancreatic cancer are not currently available. We evaluated the usefulness of a novel serum marker, REG4, in the diagnosis of pancreatic cancer, as compared to carbohydrate antigen (CA) 19-9...
  22. ncbi Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer
    Yuji Kobayashi
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Hepatogastroenterology 57:1631-4. 2010
    ..We evaluated the usefulness of a novel serum marker, REG4, as compared to that of CA19-9, CEA, and pepsinogen...
  23. ncbi Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-0021, Japan
    J Hepatobiliary Pancreat Surg 10:142-6. 2003
    ..They are effective for differential diagnosis, for assessing the degree of malignancy, and for deciding upon an appropriate treatment in patients with IPMTs...
  24. ncbi Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach
    Kenji Okubo
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, 464-8681 Nagoya, Japan
    J Gastroenterol 39:747-53. 2004
    ..When used with MIB-1 staining, the procedure may indicate GIST prognosis and influence decisions regarding therapeutic strategies...
  25. ncbi Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour
    Yasuyuki Okamoto
    Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    Gut 61:392-401. 2012
    ..Our aim was to establish epigenetic profiles associated with the malignant transformation of GISTs...
  26. ncbi A case of colonic morule with colitis cystica profunda
    Masahiro Tajika
    Department of Endoscopy, Gastroenterology, and Gastroenterological Surgery, Division of Pathology and Molecular Diagnosis, Aichi Cancer Center Hospital, Nagoya City, Japan
    Gastrointest Endosc 65:162-3; discussion 163. 2007
  27. ncbi Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA
    Nobumasa Mizuno
    Department of Gastroenterology, Aichi Cancer Center Hospital, and Nagoya University Graduate School of Medicine, 1 1 Kanokoden, Chikusa ku, Nagoya, 464 8681, Japan
    J Gastroenterol 44:742-50. 2009
    ..The aim of this study was to evaluate the feasibility and safety of endoscopic ultrasonography (EUS)-guided trucut biopsy (TCB) for diagnosis of autoimmune pancreatitis (AIP)...
  28. ncbi Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy
    Osamu Nakahara
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    J Gastroenterol 44:562-7. 2009
    ..The aim of this study was to evaluate the yield of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in patients with undiagnosed intra-abdominal lymphadenopathy...
  29. ncbi Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-0021, Japan
    J Gastroenterol 38:690-4. 2003
    ..This case report describes a highly effective use of STI571 in a 54-year-old woman with multiple liver metastases from a GIST originating in the duodenum...
  30. ncbi Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses
    Takeshi Ogura
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 75:769-74. 2012
    ..EUS-guided FNA (EUS-FNA) is considered optimal for differentially diagnosing pancreatic masses. However, the sensitivity of EUS-FNA ranges from 65% to 95%, respectively, which requires improvement...
  31. ncbi ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection
    Makoto Nakao
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Chikusa ku, Nagoya, Japan
    Cancer Epidemiol Biomarkers Prev 20:1665-72. 2011
    ....
  32. ncbi Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer
    Reiko Ashida
    Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 28:83. 2009
    ..The aim of this study was to determine a predictive indicator of gemcitabine (GEM) efficacy in unresectable pancreatic cancer using tissue obtained by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA)...
  33. ncbi Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis?
    Susumu Hijioka
    Department of Gastroenterology, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
    Gastrointest Endosc 72:622-7. 2010
    ..EUS-guided FNA (EUS-FNA) is a useful modality for sampling various targets, but its applicability to gallbladder (GB) mass lesions is limited...
  34. ncbi Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors
    Mohamed A Mekky
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 71:913-9. 2010
    ..The addition of EUS-guided FNA (EUS-FNA) has the potential to improve this distinction, but published series are limited...
  35. ncbi Risk factors for vitamin D deficiency in patients with Crohn's disease
    Masahiro Tajika
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, 464-8681, Nagoya, Japan
    J Gastroenterol 39:527-33. 2004
    ..25-OHD levels should be assessed in patients who have had Crohn's disease for a long time (>15 years) and who have been in the active stage of the disease for long periods...
  36. ncbi EUS-Guided Biliary Drainage
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gut Liver 4:S67-75. 2010
    ....
  37. ncbi Interventional endoscopic ultrasonography for pancreatic cancer
    Kazuo Hara
    Kazuo Hara, Kenji Yamao, Nobumasa Mizuno, Susumu Hijioka, Akira Sawaki, Masahiro Tajika, Hiroki Kawai, Shinya Kondo, Yasumasa Niwa, Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya 464 8681, Japan
    World J Clin Oncol 2:108-14. 2011
    ..This review focuses on interventional EUS, including EUS-FNA and therapeutic EUS for pancreatic cancer...
  38. ncbi [A case of anaplastic ductal carcinoma (giant cell carcinoma of osteoclastoid type) with portal vein and main pancreatic ductal invasion]
    Toshifumi Isaka
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nippon Shokakibyo Gakkai Zasshi 102:736-40. 2005
  39. ncbi Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk
    Takeshi Suzuki
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
    Cancer Epidemiol Biomarkers Prev 17:2742-7. 2008
    ..17-6.00) in the MTR 2756 AA genotype, and 3.35 (1.34-8.36) in the MTRR 66 G allele carriers. These results suggest that the folate-related enzyme polymorphism modifies the association between drinking habit and pancreatic cancer risk...
  40. ncbi Short-term development of esophageal pyogenic granuloma observed on endoscopy
    Masahiro Tajika
    Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya City, Japan
    Gastrointest Endosc 64:269-70. 2006
  41. ncbi EUS-guided choledochoduodenostomy for palliative biliary drainage in case of papillary obstruction: report of 2 cases
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 64:663-7. 2006
  42. ncbi Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer
    Takeshi Ogura
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nihon Shokakibyo Gakkai Zasshi 108:1712-9. 2011
    ..We treated her with hemodialysis, plasmapheresis and immune suppression with prednisolone, which improved the anemia and renal failure...
  43. ncbi Metastasis of uterine leiomyosarcoma to the pancreas -Usefulness and limitations of EUS-FNA-
    Takeshi Ogura
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nihon Shokakibyo Gakkai Zasshi 108:987-96. 2011
    ..Therefore, the final diagnosis was extremely rare metastatic leiomyosarcoma of the pancreas. Herein, we report metastasis of uterine leiomyosarcoma to the pancreas and discuss the usefulness and limitations of EUS-FNA...
  44. ncbi Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Nagoya 464-8681, Japan
    J Gastroenterol 40:1013-23. 2005
    ....
  45. ncbi Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, 464 8681, Aichi, Japan
    Invest New Drugs 29:688-93. 2011
    ..1 months. Grade 2 skin toxicity was observed in 23 patients, while no grade 3 skin toxicity was observed. Combined irinotecan and cetuximab is effective for pretreated metastatic wild-type KRAS colorectal cancer...
  46. ncbi Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA
    Kuniyuki Takahashi
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 61:76-9. 2005
    ..Analysis for the K-ras point mutation in specimens obtained by EUS-guided FNA may enhance diagnostic accuracy in indeterminate cases...
  47. ncbi Pancreaticobiliary maljunction in monozygotic twins--a case report
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Hepatogastroenterology 51:675-8. 2004
    ..This case is not only of academic interest for familial occurrence, but also of clinical interest in the early detection of pancreaticobiliary maljunction...
  48. ncbi Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience
    Yoshinari Mochizuki
    Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
    Surg Today 36:341-7. 2006
    ..CONCLUSION: Laparoscopic wedge resection is a feasible treatment option for GISTs of the stomach if the lesion is <5 cm in diameter...
  49. ncbi [Cytologic diagnosis of pancreatic cancer]
    Hiroyuki Inoue
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nippon Rinsho 64:135-9. 2006
  50. ncbi Endoscopic ultrasound-guided choledochoduodenostomy
    Kazuo Hara
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
    Dig Endosc 22:147-50. 2010
    ..We think transduodenal direct access is the best treatment in patients with jaundice caused by inoperable malignant obstruction of the lower extrahepatic bile duct when EBD fails...
  51. ncbi A two-step method for marking polypectomy sites in the colon and rectum
    Akira Sawaki
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 57:735-7. 2003
    ..At surgery, all lesions were immediately visualized. CONCLUSION: The two-step tattooing method proved to be easy, safe, and accurate for marking polypectomy sites...
  52. ncbi Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers
    Byonggu An
    Division of Molecular Oncology, Aichi Cancer Center Research Institute, Chikusa ku, Nagoya 464 8681, Japan
    Int J Cancer 127:2095-105. 2010
    ....
  53. ncbi Efficacy of peroral pancreatoscopy in the diagnosis of pancreatic diseases
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
    Gastrointest Endosc 57:205-9. 2003
    ..Peroral pancreatoscopy with a thin fiberscope can provide a definitive diagnosis of intraductal papillary-mucinous tumor including the degree of malignancy...
  54. ncbi Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1
    Kohei Shitara
    Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
    Jpn J Clin Oncol 38:786-9. 2008
    ..3 versus 2.3 months, P = 0.02). S-1-containing chemotherapy does not appear to be effective in patients whose gastric cancer recurs after adjuvant S-1 chemotherapy. Other chemotherapeutic agents should be evaluated in this setting...
  55. ncbi Risk factors for pancreatic cancer and early diagnosis of pancreatic cancer
    Kenji Yamao
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nippon Shokakibyo Gakkai Zasshi 105:8-16. 2008
  56. ncbi Smoking increases the treatment failure for Helicobacter pylori eradication
    Takeshi Suzuki
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
    Am J Med 119:217-24. 2006
    ..CONCLUSIONS: Our meta-analysis demonstrated that smoking increases the treatment failure rate for H. pylori eradication...
  57. ncbi Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese
    Keitaro Matsuo
    Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464 8681, Japan
    Int J Cancer 125:1961-4. 2009
    ..No association was seen between PSCA polymorphisms and H. pylori infection. In conclusion, PSCA polymorphisms are associated with stomach cancer risk in Japanese. A possible interaction with family history warrants further evaluation...
  58. ncbi [A case of Crohn's disease with osteomalacia detected by bone fracture]
    Masahiro Tajika
    Department of Gastroenterology, Aichi Cancer Center Hospital
    Nippon Shokakibyo Gakkai Zasshi 99:1481-6. 2002
  59. ncbi Long-term effects of donepezil on P300 auditory event-related potentials in patients with Alzheimer's disease
    Eiichi Katada
    Department of Internal Medicine, Nagoya City Johoku Hospital, Nagoya, Japan
    J Geriatr Psychiatry Neurol 16:39-43. 2003
    ..P300 latency gives very useful information on the progression of AD, especially in the longitudinal follow-up of patients with AD during treatment with DPZ acting on cholinergic pathways...
  60. ncbi Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
    Toshirou Nishida
    Department of Surgery, Osaka University Graduate School of Medicine, 2 2 Yamada oka, Suita, Osaka 565 0871, Japan
    Int J Clin Oncol 13:244-51. 2008
    ..The aim of this study was to assess the efficacy and safety of imatinib mesylate in Japanese patients with advanced GIST...